Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Midatech Pharma PLC

3 Jul 2020 07:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Intracoastal Capital LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Midatech Pharma Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18/May/20

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

YES / NO / N/A

If YES, specify which:N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Warrant to purchase ADR’s

Details, including nature of the rights concerned and relevant percentages:

238,392 Warrants with a strike price of USD$2.05 for an equivalent number of ADR’s

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

ADR’s ISIN -US59564R3021

Sale

 

238,392

$1.57USD

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

ADR’s ISIN -US59564302

Receipt of Placement of ADR’s

238,392

$1.65USD

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

 

none

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

 

none

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

6/25/20

Contact name:

Mitchell Kopin

Telephone number*:

847-562-9030

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200702005540/en/

Copyright Business Wire 2020

Date   Source Headline
16th Sep 20215:00 pmRNSOfficial Opening of New Cardiff Headquarters
17th Aug 20215:23 pmRNSChange of Registered Office
15th Jul 202110:28 amRNSGrant of Options and PDMR dealings
12th Jul 20212:30 pmRNSAppointment of Chief Scientific Officer
7th Jul 202111:21 amRNSHolding(s) in Company
30th Jun 202112:07 pmRNSResult of AGM
29th Jun 20217:00 amRNSUK Placing to Raise £10.0 million
18th Jun 20214:29 pmRNSHolding(s) in Company
17th Jun 20214:41 pmRNSSecond Price Monitoring Extn
17th Jun 20214:35 pmRNSPrice Monitoring Extension
17th Jun 20212:05 pmRNSSecond Price Monitoring Extn
17th Jun 20212:00 pmRNSPrice Monitoring Extension
17th Jun 202111:00 amRNSPrice Monitoring Extension
17th Jun 20217:00 amRNSBreakthrough data using Q-Sphera technology
9th Jun 20217:00 amRNSInvestor Webinar Scheduled for 17 June 2021
21st May 20213:56 pmRNSPosting of Annual Report & Notice of AGM
30th Apr 20212:05 pmRNSResults for the Year Ended 31 December 2020
25th Mar 20217:00 amRNSMTX110 Update & Headline Results for 2020
17th Feb 20217:00 amRNSExercise of Warrants and Issue of Equity
16th Feb 20215:46 pmRNSHolding(s) in Company
15th Feb 20214:12 pmRNSHolding(s) in Company
11th Feb 20216:20 pmRNSHolding(s) in Company - Replacement
11th Feb 20213:42 pmRNSHolding(s) in Company
5th Feb 20219:05 amRNSSecond Price Monitoring Extn
5th Feb 20219:00 amRNSPrice Monitoring Extension
26th Jan 20212:06 pmRNSSecond Price Monitoring Extn
26th Jan 20212:01 pmRNSPrice Monitoring Extension
26th Jan 202110:30 amRNSBusiness Update
8th Jan 20214:40 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
11th Dec 20205:00 pmRNSMTX110 Programmes to be presented at ISPNO 2020
11th Dec 202010:00 amRNSLaunch of new website
9th Dec 20207:00 amRNSParliament Highlights Need for New DIPG Treatments
24th Nov 20207:00 amRNSMTX110 presented at 2020 Annual SNO Conference
19th Oct 20204:40 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
19th Oct 202011:06 amRNSSecond Price Monitoring Extn
19th Oct 202011:00 amRNSPrice Monitoring Extension
19th Oct 20207:00 amRNSHeadline Results of MTX110 Phase I DIPG Study
30th Sep 20205:54 pmRNSIssue of Equity for Employee Share Incentive Plan
23rd Sep 202011:42 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSHolding(s) in Company
10th Sep 20207:00 amRNSInterim results - 6 months ended 30 June 2020
7th Sep 20207:00 amRNSInvestor Webinar
28th Aug 20207:00 amRNSNotice of Interim Results
25th Aug 20202:51 pmRNSHolding(s) in Company
21st Aug 20202:06 pmRNSSecond Price Monitoring Extn
21st Aug 20202:00 pmRNSPrice Monitoring Extension
19th Aug 20207:00 amRNSExercise of Warrants and Issue of Equity
17th Aug 20205:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.